Illumina, which has an estimated 80% share of the global gene sequencing market, unveiled a new line of instruments today that it says will cut the cost of genome sequencing — the latest in a flurry of announcements from an industry in pursuit of faster and cheaper offerings."It's Illumina's response to the competition," says Jay Shendure, a professor of genome sciences at the University of Washington.
"It's the way we measure things in biology," Shendure says. "For a lot of science, [the cost of sequencing] is like the price of gas." And the cost — about $600 to sequence a human genome today, according to Illumina — is still limiting for many projects and goals. "It's something a large fraction of the community needs and when someone comes along and says it will significantly cut the price of gas, it is a big deal," he says.Illumina says its new sequencers, NovaSeq X and NovaSeq X Plus, are twice as fast as the existing NovaSeq sequencer that is widely used across industry and academic institutions.
The roughly $1 million sequencers, which will begin to be shipped in 2023, can sequence a human genome for less than $240 — the company's "biggest step forward" in its chemistry since first launching a sequencer 17 years ago, Illumina CEO Francis deSouza told me earlier this year. Sequencing a human genome
GATTACA
$ILMN owns 80% of the gene sequencing market 🧬 And the cost of sequencing each gene is currently at $600 Ultimate Genomics is looking to make the cost of gene sequencing as low as $100 per gene. This large cap has startup competition.
Long $ILMN $TXG
Long $DNA
Introducing, the poop detector, exclusively through Amazon
This sounds extremely dubious. Do not support these companies. Your data is sold.
More sponsored crap needed!